Veterinary Molecular Diagnostics Market Size
At CAGR of 8.6%, the USD 298 million veterinary molecular diagnostics market is expected to reach USD 678.8 million by 2032. Among the main causes are growing acceptance of companion animals, high frequency of zoonotic and foodborne diseases, developments in veterinary molecular diagnostics technologies, and growing acceptance of pet insurance.
To get key market trends
Veterinary molecular diagnostics is the application of molecular techniques such polymerase chain reaction (PCR), next-generation sequencing (NGS), and microarray to identify infectious illnesses, genetic problems, and other ailments in animals. Products used for the examination of animal DNA, RNA, and proteins to find certain nucleic acid sequences or mutations linked with sickness or predisposition to disease are part of the industry. To support the accurate diagnosis, treatment, and illness prevention in animals, these diagnostic tests are carried out in diagnostic laboratories, veterinary hospitals and clinics, research institutes, and other animal care facilities.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Veterinary Molecular Diagnostics Market Size in 2022 | USD 298 Million |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 8.6% |
| 2032 Value Projection | USD 678.8 Million |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 313 |
| Tables, Charts & Figures | 539 |
| Segments covered | Product, Technology, Application, Animal Type, End-user, and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
What are the growth opportunities in this market?
COVID-19 Impact
The veterinary testing sector globally has seen a rollercoaster ride under the COVID-19 epidemic. Like most things, veterinary clinics and hospitals had to cope with closed doors and limited services during the worst of it because of lockdowns, social separation, and emphasizing on what patients most needed treatment for. Paws-up just for major events. The epidemic also put the supply chain into disarray, making it more difficult to obtain the tools, reagents, test kits, and machines vets required for test running. Delays in delivery resulted from nations closing their borders, transportation issues, and a sudden demand for some goods scheduled to be imported. But the limitations relaxed and more animals could receive the required care at veterinary clinics and hospitals as COVID cases started to slow down.
Veterinary Molecular Diagnostics Market Driving Factors
Alright, here is the material you sent rewritten in a human-like mannerDemand for animal diagnostic tests Examinations Skyrockets as Pet Popularity Soars Pet ownership is rising, hence need for animal diagnostic testing has increased as well. There are a few factors driving this increase in demand1. More Pets, More ProblemsOur houses now feature more pets than they did years ago. For instance, seventy percent of American homes feature at least one pet. That is many furry friends! More pets also present more chances for them to become sick or damaged. Pet insurance is getting more and more prevalent, so individuals are more likely to be able to afford diagnostic testing for their animals. This has raised the market for these tests' demand. 3. Healthcare CostsOur pet's medical expenses are increasing our own. We want our pets to receive the finest possible treatment, hence part of this is related to treating them like family members. We are thus ready to pay for diagnostic tests that can assist to identify and treat their diseases. Diseases classified as zoonotic are those which humans can contract from animals. These diseases are becoming more and more of a cause for worry, so demand for animal diagnostic tests is rising as well. Testing animals for zoonotic diseases helps us to safeguard people as well as animals. Common testing include molecular technologies such PCR and Next-Generation Sequencing (NGS) as well as other tests meant to identify genetic abnormalities, infectious illnesses, and several health issues in animals. The demand for animal diagnostic tests, including molecular diagnostic tests, will keep rising as the number of pets increases and consumers get more conscious of the need of animal health. For businesses developing and producing these tests, this expansion presents a fantastic prospect.
You are aware of the frightening COVID-19 epidemic that struck us some time ago? Being a deadly zoonotic illness, it jumped from animals to humans. This let us understand the seriousness of several zoonotic diseases. Like secret time bombs, they are ready to explode from animals to humans and generate a great lot of disturbance. Consider avian flu, rabies, even other coronaviruses. These are all zoonotic diseases that highlight the need of early detection, monitoring, and halting of these diseases in their tracks. Veterinary molecular approaches then become rather important. In the realm of animal health, they resemble highly skilled detectives. These methods, including DNA sequencing and PCR, enable us to identify these zoonotic troublemakers among our friends—furred, feathered, even wild. Knowing which harmful pests lurk in our animals, cattle, and wild life can help us to guard ourselves and our cherished animal friends from illness.
Veterinary Molecular Diagnostics Market Analysis
Learn more about the key segments shaping this market
Hello, let us discuss the expanding veterinary molecular diagnostics business. Everything revolves on employing sophisticated methods to identify diseases in animals. Kits and reagents as well as instruments define two primary groups within the market. Project what the show's star would be. It is reagents and kits! They are akin to the tools and components vets use for disease diagnosis. They were valued shockingly at $209 million in 2022. Why are they rather well-liked? People are indeed growing increasingly concerned about diseases in farm animals and pets. Thus, there is an explosive demand for diagnostics able to rapidly and precisely identify these diseases. Moreover, vets are appreciating these kits' and reagent's simplicity. They don't call for elaborate training or specific lab equipment; they are simple to operate. Therefore, even without a fully equipped lab, vets can use them in several healthcare environments. Not less importantly, these reagents and kits are like the Lego bricks of diagnosis. Since they are meant to be user-friendly, vets and other medical professionals can quickly employ them to find animal problems.
Based on technology, the global veterinary molecular diagnostics market is categorized into PCR, DNA sequencing, microarray, and INAAT kits. PCR segment is further sub-categorized into real-time PCR and other PCRs. In 2022, the PCR segment is expected to witness considerable growth at CAGR of 8.9% by 2032. It is because PCR technology has been proven to be the most reliable and fastest technique to diagnose the cause of diseases. PCR offers high sensitivity, specificity, and rapid results, making it a valuable tool for the detection and monitoring of various infectious diseases in animals.
Based on application, the veterinary molecular diagnostics market is segmented into infectious, genetic, and other applications. The infectious diseases segment is sub-segmented into bacterial, viral, parasitic, and other infectious diseases. The infectious disease segment is expected to reach USD 362.3 million by 2032. The rising prevalence of infectious diseases in animals is high, driving the demand for accurate and timely diagnostics to identify and treat such diseases. Due to the high emphasis on public health and animal health, there is a high demand for the early detection and control of zoonotic diseases.
Learn more about the key segments shaping this market
When it comes to veterinary molecular diagnostics, the market is split into two main groupsanimals we keep as companions and animals raised for food. For our furry friends, the companion animal market includes dogs, cats, horses, and other adorable creatures. On the livestock side, we've got cattle, pigs, chickens, and plenty more. Companion animals have been dominating the market, holding nearly two-thirds of it in 2022. The reason? We're crazy about our pets! More and more people are bringing dogs and cats into their homes, and we're spending more on their health and well-being. We love them like family, so we want to make sure they're happy and healthy. And with pet insurance becoming more popular, we're even more likely to seek veterinary care for our beloved companions. What's more, we're treating our pets more like humans these days. We're taking them for regular checkups and vaccinations, and we're even using molecular diagnostics to monitor their health and prevent illnesses. It's all part of our commitment to keeping our furry friends by our side for as long as possible.
Based on end-user, the veterinary molecular diagnostics market is classified into diagnostic laboratories, veterinary clinics, veterinary hospitals, and other end-users. Diagnostic laboratories segment is expected grow at CAGR of 8.6% by 2032. Veterinary diagnostic laboratories have specialized expertise, skilled personnel, and well-equipped facilities for performing molecular diagnostics. Such laboratories have well-developed infrastructure, including advanced laboratory devices which improves the handling of complex diagnostic procedures effectively and precisely. It offers a wide range of molecular tests for diagnosing various infectious diseases, genetic conditions, and immune-related disorders in animals.
Looking for region specific data?
North America veterinary molecular diagnostics market is expected to grow at CAGR of 8.1% by 2032. North America has well-developed veterinary healthcare infrastructure, including veterinary hospitals, clinics, and specialized veterinary centers. The presence of skilled veterinarians, advanced veterinary diagnostic equipment and techniques, and a wide range of treatments and veterinary services.
The U.S. is one of the countries which has the largest pet populations in the world, with a significant number of households owning pets. In U.S., dogs and cats are the most common pets, but there is also a considerable population of birds, fish, small mammals, and reptiles.
Veterinary Molecular Diagnostics Market Share
The prominent players in the veterinary molecular diagnostics market are
- IDEXX Laboratories Inc.
- Thermo Fischer Scientific Inc.
- bioMerieux SA
- Qiagen
- ID Vet
- Biolab S.r.l.
- INDICAL BIOSCIENCE GmbH
- Bionote USA Inc.
- Zoetis, Inc.
- Neogen Corporation
Veterinary Molecular Diagnostics Industry News
- In June 2022, IDEXX Laboratories, Inc expanded the reference laboratory menu by including Fecal Dx Antigen Testing with Flea Tapeworm Detection, Testing for the FGF-23 Kidney Biomarker, and Next-Day PCR Direct Testing Service. This strategy helped the company to enhance its existing product portfolio and increase customer base.
- In December 2021, Neogen Corporation acquired Spokane-based Genetic Veterinary Sciences, Inc., companion animal genetic testing company. This strategic acquisition helped the company to expand its genomics business and outreach to untapped economies.
The global veterinary molecular diagnostics market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
By Product
- Kits & Reagents
- Instrument
By Technology
- PCR
- Real Time PCR
- Other PCRs
- DNA sequencing
- Microarrays
- INAAT kits
By Application
- Infectious diseases
- Bacterial infectious diseases
- Viral infectious diseases
- Parasitic infectious diseases
- Other infectious diseases
- Genetic diseases
- Other applications
By Animal Type
- Companion animals
- Dogs
- Cats
- Horses
- Other companion animals
- Livestock animals
- Cattle
- Swine
- Poultry
- Other livestock animals
By End-user
- Diagnostic laboratories
- Veterinary clinics
- Veterinary hospitals
- Other end-users
The above information is provided for the following regions and countries
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- South Africa
- Saudi Arabia
- Rest of Middle East & Africa
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy